|
Q3 FY2026
As of May 31, 2026
|
Q2 FY2026
As of Feb 28, 2026
|
Q1 FY2026
As of Nov 30, 2025
|
Q4 FY2025
As of Aug 31, 2025
|
Q3 FY2025
As of May 31, 2025
|
Q2 FY2025
As of Feb 28, 2025
|
Q1 FY2025
As of Nov 30, 2024
|
Q4 FY2024
As of Aug 31, 2024
|
Q3 FY2024
As of May 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash and cash equivalents | |||||||||
| Cash and cash equivalents | |||||||||
| Prepaid expenses | |||||||||
| Accounts receivable | |||||||||
| Total current assets | |||||||||
| Computer and Software | |||||||||
| Inventory | |||||||||
| Total non-current assets | |||||||||
| TOTAL ASSETS | |||||||||
| Current Liabilities | |||||||||
| Advances from related party | |||||||||
| Accounts payable | |||||||||
| Prepaid sales deposit | |||||||||
| Total current liabilities | |||||||||
| Total Liabilities | |||||||||
| Commitments and Contingencies | |||||||||
| Stockholders' Equity | |||||||||
| Common stock, $0.001 par value, 75,000,000 shares authorized; 15,337,250 shares issued and outstanding | |||||||||
| Common stock subscribed, 7,985,000 shares | |||||||||
| Additional paid-in-capital | |||||||||
| Accumulated deficit | |||||||||
| Total Stockholders' Equity (Deficit) | |||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
Loading...
